HIV-1 genotypic resistance in treatment-naive subjects enrolled in an observational trial (GAIN)

被引：0
|
作者：
Becker, MI
Haubrich, R
Wesselman, CW
Garrett, L
Lee, SY
Millard, D
Baxter, JD
机构：
[1] Agouron Pharmaceut Inc, La Jolla, CA USA
[2] UCSD, San Diego, CA USA
[3] Ingenix Pharmaceut Serv, Basking Ridge, NJ USA
[4] Consolidated Lab Serv, Van Nuys, CA USA
[5] RWJ Med Sch, Camden, NJ USA
来源：
ANTIVIRAL THERAPY | 2002年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
161
引用
下载
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [1] Characterization of Emergent HIV Resistance in Treatment-Naive Subjects Enrolled in a Vicriviroc Phase 2 Trial
    McNicholas, Paul
    Wei, Yi
    Whitcomb, Jeannette
    Greaves, Wayne
    Black, Todd A.
    Tremblay, Cecile L.
    Strizki, Julie M.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (10): : 1470 - 1480
  • [2] Prevalence of primary genotypic resistance in a UK centre: comparison of primary HIV-1 and newly diagnosed treatment-naive individuals
    Fox, Julie
    Hill, Samantha
    Kaye, Steve
    McClure, Myra
    Fidler, Sarah
    Mackie, Nicola E.
    AIDS, 2007, 21 (02) : 237 - 239
  • [3] Transmission and prevalence of HIV resistance among treatment-naive subjects
    Little, SJ
    ANTIVIRAL THERAPY, 2000, 5 (01) : 33 - 40
  • [4] HIV-1 drug resistance in treatment-naive, chronically infected patients in Jamaica
    Barrow, Geoffrey J.
    Hylton-Kong, Tina
    Rodriguez, Nayra
    Yamamura, Yasuhiro
    Figueroa, J. Peter
    ANTIVIRAL THERAPY, 2013, 18 (07) : 941 - 944
  • [5] HIV-1 Drug Resistance Among Treatment-Naive Transgenders from India
    Kurle, Swarali N.
    Kandaswami, Sudarshan
    Gadhe, Sharda
    Patil, Ajit
    Sarkar, Rohit
    Mehta, Sonal
    Gangakhedkar, Raman
    Arumugam, Viswanathan
    Chawla, Umesh
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (12) : 990 - 993
  • [6] Genotypic HIV-1 drug resistance testing in antiretroviral-naive subjects in Houston, Texas
    Nannini, EC
    Han, XL
    O'Brien, WA
    Arduino, RC
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (03) : 317 - 319
  • [7] Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades
    Doyle, Tomas
    Dunn, David T.
    Ceccherini-Silberstein, Francesca
    De Mendoza, Carmen
    Garcia, Frederico
    Smit, Erasmus
    Fearnhill, Esther
    Marcelin, Anne-Genevieve
    Martinez-Picado, Javier
    Kaiser, Rolf
    Geretti, Anna Maria
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (11) : 3080 - 3086
  • [8] RaltegravirIn Treatment-Naive Patients with HIV-1 Infection
    Jamie D. Croxtall
    Lesley J. Scott
    Drugs, 2010, 70 : 631 - 642
  • [9] Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients
    Soulie, Cathia
    Malet, Isabelle
    Lambert-Niclot, Sidonie
    Tubiana, Roland
    Thevenin, Monique
    Simon, Anne
    Murphy, Robert
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    AIDS, 2008, 22 (16) : 2212 - 2214
  • [10] Raltegravir In Treatment-Naive Patients with HIV-1 Infection
    Croxtall, Jamie D.
    Scott, Lesley J.
    DRUGS, 2010, 70 (05) : 631 - 642
12345